First‐line beta‐blocker vs placebo
Total coronary heart disease · adults with primary hypertension
First‐line beta‐blocker showed no clear difference in total coronary heart disease compared with placebo (low certainty).
1 finding from 1 review
- RR 0.9 [0.78, 1.03]5 studies · 19313 participantsLow